Postoperative Nausea and Vomiting in Cancer Surgery: Present Views on the Solution of the Old Problem

Postoperative nausea and vomiting (PONV) is one of the most common and unpleasant complications after surgery. It is distressing for patients, results in increased treatment costs, and may cause very serious complications in the early postoperative period. The incidence of PONV in different surgical...

Full description

Bibliographic Details
Main Authors: D. S. Baskakov, V. E. Khoronenko
Format: Article
Language:English
Published: Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia 2013-04-01
Series:Общая реаниматология
Subjects:
Online Access:https://www.reanimatology.com/rmt/article/view/150
_version_ 1797874251007524864
author D. S. Baskakov
V. E. Khoronenko
author_facet D. S. Baskakov
V. E. Khoronenko
author_sort D. S. Baskakov
collection DOAJ
description Postoperative nausea and vomiting (PONV) is one of the most common and unpleasant complications after surgery. It is distressing for patients, results in increased treatment costs, and may cause very serious complications in the early postoperative period. The incidence of PONV in different surgical fields varies with the pattern of a surgical intervention, by assuming particular importance in cancer surgical practice where the likelihood of its development is very high for a number of reasons. A large number of studies currently deal with the development of PONV prevention schemes. Major risk factors have been identified; there are novel recommendations on anesthetic maintenance from the antiemetogenic point of view; however, the described procedures are not yet able to fully get rid of a patient’s risk for developing a complication. Drugs from a group of serotonin 5HT3-receptor antagonists and metoclopramide hydrochloride in combinations with glu-cocorticosteroids and butyrophenones are most frequently included into PONV prevention regimens. There are more and more data on the antiemetogenic activity of ^-adrenoblockers and fl^-adrenoceptor agonists and on the possibilities of using them during anesthesia. In this review, we attempted to summarize today’s accumulated knowledge about risk factors and procedures for preventing PONV and to define some new and promising areas in its prevention after cancer surgery.
first_indexed 2024-04-10T01:29:00Z
format Article
id doaj.art-1833e7be7e204a6c9c4b99ea41b429ec
institution Directory Open Access Journal
issn 1813-9779
2411-7110
language English
last_indexed 2024-04-10T01:29:00Z
publishDate 2013-04-01
publisher Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
record_format Article
series Общая реаниматология
spelling doaj.art-1833e7be7e204a6c9c4b99ea41b429ec2023-03-13T09:32:52ZengFederal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, RussiaОбщая реаниматология1813-97792411-71102013-04-019210.15360/1813-9779-2013-2-66150Postoperative Nausea and Vomiting in Cancer Surgery: Present Views on the Solution of the Old ProblemD. S. BaskakovV. E. KhoronenkoPostoperative nausea and vomiting (PONV) is one of the most common and unpleasant complications after surgery. It is distressing for patients, results in increased treatment costs, and may cause very serious complications in the early postoperative period. The incidence of PONV in different surgical fields varies with the pattern of a surgical intervention, by assuming particular importance in cancer surgical practice where the likelihood of its development is very high for a number of reasons. A large number of studies currently deal with the development of PONV prevention schemes. Major risk factors have been identified; there are novel recommendations on anesthetic maintenance from the antiemetogenic point of view; however, the described procedures are not yet able to fully get rid of a patient’s risk for developing a complication. Drugs from a group of serotonin 5HT3-receptor antagonists and metoclopramide hydrochloride in combinations with glu-cocorticosteroids and butyrophenones are most frequently included into PONV prevention regimens. There are more and more data on the antiemetogenic activity of ^-adrenoblockers and fl^-adrenoceptor agonists and on the possibilities of using them during anesthesia. In this review, we attempted to summarize today’s accumulated knowledge about risk factors and procedures for preventing PONV and to define some new and promising areas in its prevention after cancer surgery.https://www.reanimatology.com/rmt/article/view/150cancer surgerypostoperative nausea and vomitingponv preventionrisk factorsantiemetics.
spellingShingle D. S. Baskakov
V. E. Khoronenko
Postoperative Nausea and Vomiting in Cancer Surgery: Present Views on the Solution of the Old Problem
Общая реаниматология
cancer surgery
postoperative nausea and vomiting
ponv prevention
risk factors
antiemetics.
title Postoperative Nausea and Vomiting in Cancer Surgery: Present Views on the Solution of the Old Problem
title_full Postoperative Nausea and Vomiting in Cancer Surgery: Present Views on the Solution of the Old Problem
title_fullStr Postoperative Nausea and Vomiting in Cancer Surgery: Present Views on the Solution of the Old Problem
title_full_unstemmed Postoperative Nausea and Vomiting in Cancer Surgery: Present Views on the Solution of the Old Problem
title_short Postoperative Nausea and Vomiting in Cancer Surgery: Present Views on the Solution of the Old Problem
title_sort postoperative nausea and vomiting in cancer surgery present views on the solution of the old problem
topic cancer surgery
postoperative nausea and vomiting
ponv prevention
risk factors
antiemetics.
url https://www.reanimatology.com/rmt/article/view/150
work_keys_str_mv AT dsbaskakov postoperativenauseaandvomitingincancersurgerypresentviewsonthesolutionoftheoldproblem
AT vekhoronenko postoperativenauseaandvomitingincancersurgerypresentviewsonthesolutionoftheoldproblem